The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen

Clinical and Experimental Immunology

Volumn 155, Issue 1, 2009, Pages 79-87

  Porporatto, C ^a   Canali, M M ^a   Bianco, I D ^b   Correa, S G ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Antibodies; Arthritis; Chitosan; Collagen; Inflammation

Indexed keywords

ACETIC ACID; CD4 ANTIGEN; CHITOSAN; COLLAGEN TYPE 2; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; B LYMPHOCYTE; BIOCOMPATIBILITY; CONTROLLED STUDY; FEMALE; IMMUNIZATION; INFLAMMATION; LYMPH NODE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SPLEEN; T LYMPHOCYTE;

ACETIC ACID; ADMINISTRATION, ORAL; ANIMALS; ARTHRITIS, EXPERIMENTAL; CHEMOKINE CCL2; CHITOSAN; COLLAGEN TYPE II; FEMALE; FREUND'S ADJUVANT; IMMUNE TOLERANCE; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-10; LYMPH NODES; RATS; RATS, WISTAR; SPLEEN;

EID: 57449113218     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03777.x     Document Type: Article

References (59)

1. Strobel S, Mowat AM. Immune responses to dietary antigens: oral tolerance. Immunol Today 1998 19 : 173 81.
2. Weiner HL. Oral tolerance, an active immunologic process mediated by multiple mechanisms. J Clin Invest 2000 106 : 935 7.
3. Worbs T, Bode U, Yan S et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 2006 203 : 519 27.
4. Dubois B, Goubier A, Joubert G et al. Oral tolerance and regulation of mucosal immunity. Cell Mol Life Sci 2005 62 : 1322 32.
5. Husby S. Sensitization and tolerance. Curr Opin Allergy Clin Immunol 2001 1 : 237 41.
6. Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects - an update. J Pharm Pharmacol 2001 53 : 1047 67.
7. Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr 2004 79 : 529 36.
8. Wedmore I, McManus JG, Pusateri AE et al. A special report on the chitosan based hemostatic dressing: experience in current combat operations. J Trauma 2006 60 : 655 8.
9. Read RC, Naylor SC, Potter CW. Effective nasal influenza vaccine delivery using chitosan. Vaccine 2005 23 : 4367 74.
10. Illum L, Jabbal-Gill I, Hinchcliffe M et al. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev 2001 51 : 81 96.
11. Feldmann M. Pathogenesis of arthritis: recent research progress. Nat Immunol 2001 2 : 771 3.
12. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003 423 : 356 61.
13. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977 146 : 857 68.
14. Wooley PH, Luthra HS, Stuart JM et al. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981 154 : 688 700.
15. Choy EH. Oral toleragens in rheumatoid arthritis. Curr Opin Invest Drugs 2000 1 : 58 62.
16. Kalden JR, Sieper J. Oral collagen in the treatment of rheumatoid arthritis. Arthritis Rheum 1998 41 : 191 4.
17. Barnett ML, Kremer JM, St Clair EW et al. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 1998 41 : 290 7.
18. MacDonald TT, Monteleone G. IL-12 and Th1 immune responses in human Peyer's patches. Trends Immunol 2001 22 : 244 7.
19. Postlethwaite AE. Can we induce tolerance in rheumatoid arthritis? Curr Rheumatol Rep 2001 3 : 64 9.
20. Leishman AJ, Garside P, AMcI M Induction of oral tolerance in the primed immune system: influence of antigen persistence and adjuvant form. Cell Immunol 2000 202 : 71 8.
21. Porporatto C, Bianco ID, Cabanillas AM et al. Early events associated to the oral co-administration of type II collagen and chitosan: induction of anti-inflammatory cytokines. Int Immunol 2004 16 : 433 41.
22. Porporatto C, Bianco ID, Correa SG. Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration. J Leukoc Biol 2005 78 : 62 9.
23. Ausar SF, Beltramo DM, Castagna LF et al. Treatment of rheumatoid arthritis by oral administration of bovine tracheal type II collagen. Rheumatol Int 2001 20 : 138 44.
24. Bianco ID, Balsinde J, Beltramo DM et al. Chitosan-induced phospholipase A2 activation and arachidonic acid mobilization in P388D1 macrophages. FEBS Lett 2000 466 : 292 4.
25. Campo GM, Avenoso A, Campo S. Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res Ther 2003 5 : R122 31.
26. Alpan O, Rudomen G, Matzinger P. The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J Immunol 2001 166 : 4843 52.
27. Kim WU, Lee WK, Ryoo JW et al. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance. Arthritis Rheum 2002 46 : 1109 20.
28. Baig SM. Anti-purified protein derivative cell-enzyme-linked immunosorbent assay, a sensitive method for early diagnosis of tuberculous meningitis. J Clin Microbiol 1995 33 : 3040 1.
29. Grunow R, D'Apuzzo M, Wyss-Coray T et al. A cell surface ELISA for the screening of monoclonal antibodies to antigens on viable cells in suspension. J Immunol Methods 1994 171 : 93 102.
30. Brand DD, Myers LK, Whittington KB et al. Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model. J Immunol 2002 168 : 490 8.
31. Porporatto C, Bianco ID, Riera CM et al. Chitosan induces different L-arginine metabolic pathways in resting and inflammatory macrophages. Biochem Biophys Res Commun 2003 304 : 266 72.
32. Borzi RM, Mazzetti I, Macor S et al. Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett 1999 455 : 238 42.
33. Seki N, Sudo Y, Yoshioka T et al. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 1988 140 : 1477 84.
34. Smith KM, McAskill F, Garside P. Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant, but they remain unable to provide B cell help. J Immunol 2002 168 : 4318 25.
35. Thorbecke GJ, Schwarcz R, Leu J et al. Modulation by cytokines of induction of oral tolerance to type II collagen. Arthritis Rheum 1999 42 : 110 8.
36. DePaolo RW, Rollins BJ, Kuziel W et al. CC Chemokine ligand 2 and its receptor regulate mucosal production of IL-12 and TGF-β in high dose oral tolerance. J Immunol 2003 171 : 3560 7.
37. Min SY, Hwang SY, Park KS et al. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Arthritis Res Ther 2004 6 : R213 9.
38. Battaglia M, Gianfrani C, Gregori S et al. IL-10-producing T regulatory type 1 cells and oral tolerance. Ann NY Acad Sci 2004 1029 : 142 53.
39. Yoshino S, Quattrocchi E, Weiner HL. Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen. Arthritis Rheum 1995 38 : 1092 6.
40. Silverman GA, Peri BA, Fitch FW et al. Enterically induced regulation of systemic immune responses. I. Lymphoproliferative responses in mice suppressed by ingested antigen. J Immunol 1983 131 : 2651 5.
41. Mazmanian SK, Liu CH, Tzianabos AO et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005 122 : 107 18.
42. Ruiz-Perez B, Chung DR, Sharpe AH et al. Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. Proc Natl Acad Sci USA 2005 102 : 16753 8.
43. Kim GY, Kim SH, Hwang SY et al. Oral administration of proteoglycan isolated from Phellinus linteus in the prevention and treatment of collagen-induced arthritis in mice. Biol Pharm Bull 2003 26 : 823 31.
44. Sugihara R, Yoshimura M, Mori M, Kanayama N, Hikida M, Ohmori H. Prevention of collagen-induced arthritis in DBA/1 mice by oral administration of AZ-9, a bacterial polysaccharide from Klebsiella oxytoca. Immunopharmacology 2000 49 : 325 33.
45. Taravel MN, Domard A. Collagen and its interactions with chitosan. III. Some biological and mechanical properties. Biomaterials 1996 17 : 451 5.
46. Hall G, Lund L, Lamb JR et al. Kinetics and mode of peptide delivery via the respiratory mucosa determine the outcome of activation versus TH2 immunity in allergic inflammation of the airways. J Allergy Clin Immunol 2002 110 : 883 90.
47. Illum L, Farraj NF, Davis SS. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res 1994 11 : 1186 9.
48. Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005 206 : 232 59.
49. Mayer L. Mucosal immunity. Pediatrics 2003 111 : 1595 600.
50. Moser M. Dendritic cells in immunity and tolerance - do they display opposite functions? Immunity 2003 19 : 5 8.
51. Weiner HL. The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol 2001 2 : 671 2.
52. Viney JL, Mowat AM, O'Malley JM et al. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol 1998 160 : 5815 25.
53. Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J Immunol 2001 166 : 4884 90.
54. Chen Y, Kuchroo VK, Inobe J et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994 265 : 1237 40.
55. Paimela L, Johansson-Stephansson EA, Koskimies S et al. Depressed cutaneous cell-mediated immunity in early rheumatoid arthritis. Clin Exp Rheumatol 1990 8 : 433 7.
56. Min SY, Park KS, Cho ML et al. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis. Arthritis Rheum 2006 54 : 887 98.
57. Groux H, O'Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997 389 : 737 42.
58. Yudoh K, Matsuno H, Nakazawa F et al. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum 2000 43 : 617 27.
59. Gutgemann I, Fahrer AM, Altman JD et al. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 1998 8 : 667 73.